Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Receives Consensus Rating of "Buy" from Brokerages

Key Points

• Analysts give Evolv Technologies a consensus Buy rating (6 analysts: 1 sell, 3 buy, 2 strong buy) with an average 12‑month price target of $9.13.
• The company posted an earnings surprise — EPS $0.06 vs. -$0.08 est. — and revenue of $38.5M, while the stock trades around $7.11 with a 12‑month range of $4.00–$8.91 and a market cap of $1.28B.
• Director Michael Ellenbogen sold 91,771 shares at about $5.10 (insiders own 11.3%), and institutional investors hold roughly 66.65% of the shares.

Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV - Get Free Report) have earned a consensus rating of "Buy" from the six analysts that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $9.1250.

A number of equities analysts recently commented on the company. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Evolv Technologies in a research note on Tuesday, April 21st. Zacks Research upgraded Evolv Technologies from a "hold" rating to a "strong-buy" rating in a report on Monday, April 27th.

Evolv Technologies Stock Performance

Shares of EVLV stock opened at $7.11 on Thursday. The business's 50-day moving average price is $5.94 and its 200-day moving average price is $6.37. Evolv Technologies has a 12 month low of $4.00 and a 12 month high of $8.91. The firm has a market capitalization of $1.28 billion, a price-to-earnings ratio of -33.86 and a beta of 1.82. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.24.

Evolv Technologies (NASDAQ:EVLV - Get Free Report) last announced its quarterly earnings results on Tuesday, March 10th. The company reported $0.06 EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.14. The firm had revenue of $38.50 million for the quarter, compared to analyst estimates of $36.44 million. Evolv Technologies had a negative return on equity of 30.45% and a negative net margin of 22.71%. Equities research analysts forecast that Evolv Technologies will post -0.18 EPS for the current year.

Insider Activity at Evolv Technologies

In other news, Director Michael Ellenbogen sold 91,771 shares of the business's stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $5.10, for a total transaction of $468,032.10. Following the completion of the sale, the director owned 2,083,961 shares in the company, valued at $10,628,201.10. The trade was a 4.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Evolv Technologies

Institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Evolv Technologies by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 79,928 shares of the company's stock worth $249,000 after purchasing an additional 5,050 shares during the last quarter. Creative Planning purchased a new position in shares of Evolv Technologies during the 2nd quarter valued at $189,000. JPMorgan Chase & Co. lifted its position in shares of Evolv Technologies by 192.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 221,915 shares of the company's stock valued at $1,385,000 after buying an additional 146,067 shares during the last quarter. Prudential Financial Inc. purchased a new stake in Evolv Technologies during the 2nd quarter worth about $94,000. Finally, CW Advisors LLC lifted its holdings in Evolv Technologies by 19.0% during the 2nd quarter. CW Advisors LLC now owns 12,614 shares of the company's stock worth $79,000 after purchasing an additional 2,014 shares in the last quarter. Institutional investors own 66.65% of the company's stock.

Evolv Technologies Company Profile

Evolv Technologies, Inc is a publicly traded American security technology company that develops and markets AI-driven weapons detection and screening solutions. The company’s proprietary platform combines advanced sensors, computer vision software and machine learning algorithms to identify potential threats—such as firearms and knives—while minimizing false positives and preserving high throughput. Evolv’s systems are designed to replace or supplement traditional metal detectors and manual bag checks in high-traffic venues.

The company’s flagship product, Evolv Express, integrates seamlessly into existing security checkpoints, allowing guests to pass through without stopping or emptying their pockets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.